Matches in SemOpenAlex for { <https://semopenalex.org/work/W3018966518> ?p ?o ?g. }
- W3018966518 endingPage "1094" @default.
- W3018966518 startingPage "1080" @default.
- W3018966518 abstract "This study explored the anti-inflammatory effects of a glucagon-like peptide-1 receptor agonist (GLP-1RA), known as lixisenatide, on the eyes of early type 2 diabetic mice. Diabetic (db/db) mice were divided into three groups: GLP-1RA [lixisenatide (LIX)], insulin (INS) with controlled hyperglycemia based on the glucose concentration of lixisenatide, and diabetic control (D-CON). Nondiabetic control mice (db/dm) were also characterized for comparison. After 8 weeks of treatment, mRNA levels of inflammatory markers, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling, immunohistochemical staining; Western blot of glial fibrillary acidic protein (GFAP) and thioredoxin-interacting protein; and retinal thickness were assessed in the central and peripheral neurosensory retina. LIX showed decreased immunohistochemical staining for both thioredoxin-interacting protein and GFAP in the central and peripheral neurosensory retina compared with D-CON and INS, and decreased expression of these proteins in the neurosensory retina and immunohistochemical staining in the optic nerve head for GFAP compared with D-CON. The inner nuclear layer in the peripheral retina in LIX was only thinner than those of D-CON and INS. In an early type 2 diabetic mouse model, lixisenatide treatment showed superior anti-inflammatory effects on the retina and optic nerve head independent of hyperglycemia. Thus, the neuroprotective effects of lixisenatide treatment in the peripheral inner nuclear layer should be evaluated in early type 2 diabetic retinopathy." @default.
- W3018966518 created "2020-05-01" @default.
- W3018966518 creator A5000627464 @default.
- W3018966518 creator A5000983291 @default.
- W3018966518 creator A5011702145 @default.
- W3018966518 creator A5032449466 @default.
- W3018966518 creator A5037527684 @default.
- W3018966518 creator A5054540603 @default.
- W3018966518 creator A5064930948 @default.
- W3018966518 creator A5086729399 @default.
- W3018966518 date "2020-05-01" @default.
- W3018966518 modified "2023-10-16" @default.
- W3018966518 title "The Anti-Inflammatory Effects of Glucagon-Like Peptide Receptor Agonist Lixisenatide on the Retinal Nuclear and Nerve Fiber Layers in an Animal Model of Early Type 2 Diabetes" @default.
- W3018966518 cites W1598254642 @default.
- W3018966518 cites W1940712777 @default.
- W3018966518 cites W1964445339 @default.
- W3018966518 cites W1969999276 @default.
- W3018966518 cites W1975915247 @default.
- W3018966518 cites W1980131509 @default.
- W3018966518 cites W1980157635 @default.
- W3018966518 cites W1982976347 @default.
- W3018966518 cites W1982991923 @default.
- W3018966518 cites W1986824675 @default.
- W3018966518 cites W1990973379 @default.
- W3018966518 cites W1993624198 @default.
- W3018966518 cites W1993936453 @default.
- W3018966518 cites W1995969593 @default.
- W3018966518 cites W1996861095 @default.
- W3018966518 cites W1999067730 @default.
- W3018966518 cites W2000035895 @default.
- W3018966518 cites W2001614846 @default.
- W3018966518 cites W2003992010 @default.
- W3018966518 cites W2007255585 @default.
- W3018966518 cites W2011041372 @default.
- W3018966518 cites W2017058712 @default.
- W3018966518 cites W2018932672 @default.
- W3018966518 cites W2019750418 @default.
- W3018966518 cites W2020798667 @default.
- W3018966518 cites W2021459014 @default.
- W3018966518 cites W2025651276 @default.
- W3018966518 cites W2027111051 @default.
- W3018966518 cites W2029009182 @default.
- W3018966518 cites W2032203609 @default.
- W3018966518 cites W2033120468 @default.
- W3018966518 cites W2034384804 @default.
- W3018966518 cites W2036906474 @default.
- W3018966518 cites W2040168311 @default.
- W3018966518 cites W2045324717 @default.
- W3018966518 cites W2048792294 @default.
- W3018966518 cites W2052352342 @default.
- W3018966518 cites W2052998740 @default.
- W3018966518 cites W2058124698 @default.
- W3018966518 cites W2059541234 @default.
- W3018966518 cites W2061741332 @default.
- W3018966518 cites W2062199187 @default.
- W3018966518 cites W2063865446 @default.
- W3018966518 cites W2065413522 @default.
- W3018966518 cites W2065450489 @default.
- W3018966518 cites W2075511251 @default.
- W3018966518 cites W2077823374 @default.
- W3018966518 cites W2079550276 @default.
- W3018966518 cites W2083823258 @default.
- W3018966518 cites W2088387575 @default.
- W3018966518 cites W2089183158 @default.
- W3018966518 cites W2100465511 @default.
- W3018966518 cites W2102071852 @default.
- W3018966518 cites W2103122477 @default.
- W3018966518 cites W2117444367 @default.
- W3018966518 cites W2131155467 @default.
- W3018966518 cites W2146902860 @default.
- W3018966518 cites W2147679298 @default.
- W3018966518 cites W2147810846 @default.
- W3018966518 cites W2149528363 @default.
- W3018966518 cites W2150158709 @default.
- W3018966518 cites W2151367512 @default.
- W3018966518 cites W2158951820 @default.
- W3018966518 cites W2164948885 @default.
- W3018966518 cites W2169529937 @default.
- W3018966518 cites W2170492101 @default.
- W3018966518 cites W2196507910 @default.
- W3018966518 cites W2215613566 @default.
- W3018966518 cites W2300625648 @default.
- W3018966518 cites W2345944563 @default.
- W3018966518 cites W2520009790 @default.
- W3018966518 cites W2742669393 @default.
- W3018966518 cites W2760610354 @default.
- W3018966518 cites W2771067455 @default.
- W3018966518 cites W2787584324 @default.
- W3018966518 cites W2806266122 @default.
- W3018966518 cites W2905782862 @default.
- W3018966518 cites W4235291177 @default.
- W3018966518 cites W4244017022 @default.
- W3018966518 cites W4366370203 @default.
- W3018966518 doi "https://doi.org/10.1016/j.ajpath.2020.01.011" @default.
- W3018966518 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32354571" @default.
- W3018966518 hasPublicationYear "2020" @default.
- W3018966518 type Work @default.
- W3018966518 sameAs 3018966518 @default.